期刊文献+

妊娠合并肺动脉高压的早期识别及临床管理

Early Identification and Clinical Management of Pregnancy Complicated with Pulmonary Hypertension
下载PDF
导出
摘要 肺动脉高压最终会进展为循环、呼吸衰竭,而妊娠状态加重心肺负担,妊娠合并肺动脉高压是危及母体及胎儿的妊娠并发症,症状不典型,早期难以识别,死亡率高。超声心动图较右心导管检查而言,具有简单、方便、无创的优点,临床常用。妊娠合并肺动脉高压患者一经诊断,应进行多学科管理,制定个体化、全程的诊疗方案。 Pulmonary hypertension will eventually lead to circulatory and respiratory failure, and the state of pregnancy increases the burden of heart and lung. Pregnancy complicated with pulmonary hyper-tension is a pregnancy complication that endangers the mother and fetus. The symptoms are atypi-cal and difficult to identify in the early stage, and cause high mortality. Compared with right cardiac catheterization, echocardiography is simple, convenient and non-invasive, and is commonly used in clinic. Once patients are diagnosed, they should carry out multi-disciplinary management and for-mulate individual and whole-process diagnosis and treatment plans, and choose the appropriate operation and anesthesia to terminate the pregnancy in time.
作者 郑芳 邓玮
出处 《临床医学进展》 2024年第3期291-297,共7页 Advances in Clinical Medicine
  • 相关文献

参考文献9

二级参考文献71

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:117
  • 2Evangelista A, Avegliano G, Aguilar R, et al. Impact of contrast-enhanced echocardiography on the diagnostic algorithm of acute aortic dissection[J]. Eur Heart J, 2010,31(4): 472-479.
  • 3ACOG Committee on Obstetric Praetiee. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy[J]. Obstet Gynecol, 2004, 1 04(3):647-651.
  • 4Kampman MA, Balei A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretie peptide predicts cardiovascular complications in pregnant women with congenital heart disease [J]. Eur Heart J, 2014,35(11):708-715.
  • 5European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [J]. Eur Heart J. 2011,32(24):3147-3197.
  • 6Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease[J]. Circulation, 2001,104(5):515-521.
  • 7Drenthen W, Boersma E, Balei A, et al. Predictors of pregnancy complications in women with congenital heart disease[J]. Eur Heart J, 2010,31(17):2124-2132.
  • 8Hurst JW. The value of using the entire New York Heart Association' s classificationof heart and vascular disease[J]. Clin C ardiol, 2006, 29(9):415-417.
  • 9Mukoyama M, Nakao K, Hosodo K, et al. Brain natriureticpeptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest, 1991, 87(4):1402-1412.
  • 10Kim SW, Park SW, Lira SH, et al. Amount of left ventrieular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction [J]. Clin Cardiol, 2006,29(4):155-160.

共引文献806

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部